Insider Trading & Ownership - Dudley Robert Michael

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Dudley Robert Michael
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-09-28
Purchase
2023-10-02
4:37 pm
Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer
98,000$0.51$49,980180,262
(Direct)
View
2023-06-20
Purchase
2023-06-22
6:23 pm
Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer
18,607$2.6154$48,66582,262
(Direct)
View
2023-06-09
Purchase(A)
2023-06-14
4:16 pm
Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer
19,000$2.76$52,44061,155
(Direct)
View
2023-06-09
Purchase
2023-06-13
4:16 pm
Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer
19,000$2.76$52,440912,114
(Direct)
View
2022-09-14
Purchase
2022-09-16
6:44 pm
Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer
10% Owner
20,000$1.15$23,000893,114
(Direct)
View
2022-05-27
Purchase
2022-06-01
4:01 pm
Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer
10% Owner
30,000$1.8461$55,383873,114
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-05-19
Option Award
2023-05-19
8:06 pm
N/A
2033-05-18
Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer
735,000$0735,000
(Direct)
View
2022-12-12
Option Award
2022-12-14
8:11 pm
N/A
2032-12-11
Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer
10% Owner
135,000$0135,000
(Direct)
View
2022-02-01
Option Award
2022-02-03
06:03 am
N/A
2031-01-31
Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer
10% Owner
135,000$0135,000
(Direct)
View

Ownership
2021-07-08
9:54 pm
N/A
N/A
Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer
10% Owner
0$01,661,965
(Direct)
View
(A) Indicate amendment filing.